Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

C-reactive protein causes downregulation of vascular angiotensin subtype 2 receptors and systolic hypertension in mice.

Vongpatanasin W, Thomas GD, Schwartz R, Cassis LA, Osborne-Lawrence S, Hahner L, Gibson LL, Black S, Samols D, Shaul PW.

Circulation. 2007 Feb 27;115(8):1020-8. Epub 2007 Feb 5.

2.

Angiotensin II modulates renal sympathetic neurotransmission through nitric oxide in AT2 receptor knockout mice.

Stegbauer J, Vonend O, Habbel S, Quack I, Sellin L, Gross V, Rump LC.

J Hypertens. 2005 Sep;23(9):1691-8.

PMID:
16093914
3.

Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation.

Tsutsumi Y, Matsubara H, Masaki H, Kurihara H, Murasawa S, Takai S, Miyazaki M, Nozawa Y, Ozono R, Nakagawa K, Miwa T, Kawada N, Mori Y, Shibasaki Y, Tanaka Y, Fujiyama S, Koyama Y, Fujiyama A, Takahashi H, Iwasaka T.

J Clin Invest. 1999 Oct;104(7):925-35.

4.

Cardiac hypertrophy and fibrosis in chronic L-NAME-treated AT2 receptor-deficient mice.

Gross V, Obst M, Kiss E, Janke J, Mazak I, Shagdarsuren E, Müller DN, Langenickel TH, Gröne HJ, Luft FC.

J Hypertens. 2004 May;22(5):997-1005.

PMID:
15097241
5.

C-reactive protein downregulates endothelial NO synthase and attenuates reendothelialization in vivo in mice.

Schwartz R, Osborne-Lawrence S, Hahner L, Gibson LL, Gormley AK, Vongpatanasin W, Zhu W, Word RA, Seetharam D, Black S, Samols D, Mineo C, Shaul PW.

Circ Res. 2007 May 25;100(10):1452-9. Epub 2007 Apr 19.

6.

Critical role of monocyte chemoattractant protein-1 receptor CCR2 on monocytes in hypertension-induced vascular inflammation and remodeling.

Ishibashi M, Hiasa K, Zhao Q, Inoue S, Ohtani K, Kitamoto S, Tsuchihashi M, Sugaya T, Charo IF, Kura S, Tsuzuki T, Ishibashi T, Takeshita A, Egashira K.

Circ Res. 2004 May 14;94(9):1203-10. Epub 2004 Apr 1.

7.

Role of the angiotensin II AT2-subtype receptors in the blood pressure-lowering effect of losartan in salt-restricted rats.

Gigante B, Piras O, De Paolis P, Porcellini A, Natale A, Volpe M.

J Hypertens. 1998 Dec;16(12 Pt 2):2039-43.

PMID:
9886894
8.

Roles of angiotensin type 1 and 2 receptors in pregnancy-associated blood pressure change.

Takeda-Matsubara Y, Iwai M, Cui TX, Shiuchi T, Liu HW, Okumura M, Ito M, Horiuchi M.

Am J Hypertens. 2004 Aug;17(8):684-9.

PMID:
15288884
9.

C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.

Paul A, Ko KW, Li L, Yechoor V, McCrory MA, Szalai AJ, Chan L.

Circulation. 2004 Feb 10;109(5):647-55. Epub 2004 Jan 26. Erratum in: Circulation. 2004 May 11;109(18):2254.

10.

Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor- and inflammation-related pathways.

Tamarat R, Silvestre JS, Durie M, Levy BI.

Lab Invest. 2002 Jun;82(6):747-56.

PMID:
12065685
11.
12.

Type 1 angiotensin receptor (AT1-R)-mediated decrease in type 2 angiotensin receptor mRNA level is dependent on Gq and extracellular signal-regulated kinase 1//2 in AT1-R-transfected PC12 cells.

Saito M, Shinohara Y, Sasaki H, Netsu Y, Yoshida M, Nakahata N.

J Neuroendocrinol. 2008 Mar;20(3):299-308. doi: 10.1111/j.1365-2826.2008.01646.x. Epub 2008 Jan 15.

PMID:
18208547
13.

Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.

Cosentino F, Savoia C, De Paolis P, Francia P, Russo A, Maffei A, Venturelli V, Schiavoni M, Lembo G, Volpe M.

Am J Hypertens. 2005 Apr;18(4 Pt 1):493-9.

PMID:
15831358
14.

Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277.

Wienen W, Hauel N, Van Meel JC, Narr B, Ries U, Entzeroth M.

Br J Pharmacol. 1993 Sep;110(1):245-52.

15.

Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor.

Siragy HM, Inagami T, Ichiki T, Carey RM.

Proc Natl Acad Sci U S A. 1999 May 25;96(11):6506-10.

16.

Role of bradykinins and nitric oxide in the AT2 receptor-mediated hypotension.

Sosa-Canache B, Cierco M, Gutierrez CI, Israel A.

J Hum Hypertens. 2000 Apr;14 Suppl 1:S40-6.

PMID:
10854080
17.

Elevated endothelial nitric oxide bioactivity and resistance to angiotensin-dependent hypertension in 12/15-lipoxygenase knockout mice.

Anning PB, Coles B, Bermudez-Fajardo A, Martin PE, Levison BS, Hazen SL, Funk CD, Kühn H, O'Donnell VB.

Am J Pathol. 2005 Mar;166(3):653-62.

18.

Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects.

Masaki H, Kurihara T, Yamaki A, Inomata N, Nozawa Y, Mori Y, Murasawa S, Kizima K, Maruyama K, Horiuchi M, Dzau VJ, Takahashi H, Iwasaka T, Inada M, Matsubara H.

J Clin Invest. 1998 Feb 1;101(3):527-35.

19.
20.

Pressor and mesenteric arterial hyporesponsiveness to angiotensin II is an early event in haemorrhagic hypotension in anaesthetised rats.

Pieber D, Horina G, Sandner-Kiesling A, Pieber TR, Heinemann A.

Cardiovasc Res. 1999 Oct;44(1):166-75.

PMID:
10615400

Supplemental Content

Support Center